IIS: HL7 Standard Code Set
Mapping CVX to Vaccine Groups
A variety of vaccines can be used to vaccinate against a specific disease in fulfillment of the Advisory Committee on Immunization Practices (ACIP) schedule. Multiple individual vaccines that can be used to vaccinate against a disease are grouped into a Vaccine Group (sometimes known as vaccine family), and in many cases these groups represent vaccines that vaccinate against a single disease. In a few cases they represent vaccines that vaccinate against more than one disease, but are grouped together because clinicians have thought of them as a unit.
CVX codes are codes that indicate the product used in a vaccination. MVX codes are codes that indicate the manufacturer of a vaccine. These codes are maintained by the Centers for Disease Control and Prevention, Immunization Information System Support Branch (IISSB) for use in HL7 data transmission.
The goal of the table is to support mapping of CVX to vaccine groups.
Note : “uncertain formulation CVX” is the CVX code to be used if the specific formulation is not known.
Questions regarding this table should be directed to the IIS Technical Assistance Team(or use mailing address).
Available Printable versions:
Sort Table by Column: Simply click on the column heading to sort the table accordingly.
Short Description | CVX Code | Vaccine status | Vaccine Group Name | Uncertain Formulation CVX |
---|---|---|---|---|
zoster | 121 | Active | ZOSTER | |
yellow fever | 37 | Active | YELLOWFEVER | |
VZIG (IND) | 117 | Inactive | ||
VZIG | 36 | Active | ||
VEE, unspecified formulation | 92 | Inactive | VEE | 92 |
VEE, live | 80 | Inactive | VEE | 92 |
VEE, inactivated | 81 | Inactive | VEE | 92 |
varicella | 21 | Active | VARICELLA | |
vaccinia immune globulin | 79 | Active | ||
vaccinia (smallpox) diluted | 105 | Inactive | VACCINIA | |
vaccinia (smallpox) | 75 | Active | VACCINIA | |
typhus, historical | 131 | Inactive | ||
typhoid, ViCPs | 101 | Active | TYPHOID | 91 |
typhoid, unspecified formulation | 91 | Inactive | TYPHOID | 91 |
typhoid, parenteral, AKD (U.S. military) | 53 | Active | TYPHOID | 91 |
typhoid, parenteral | 41 | Active | TYPHOID | 91 |
typhoid, oral | 25 | Active | TYPHOID | 91 |
tularemia vaccine | 78 | Inactive | ||
TST-PPD tine test | 97 | Inactive | ||
TST-PPD intradermal | 96 | Inactive | ||
TST-OT tine test | 95 | Inactive | ||
TST, unspecified formulation | 98 | Inactive | ||
TIG | 13 | Active | ||
tick-borne encephalitis | 77 | Inactive | ||
tetanus toxoid, unspecified formulation | 112 | Inactive | ||
tetanus toxoid, not adsorbed | 142 | Active | ||
tetanus toxoid, adsorbed | 35 | Active | ||
Tdap | 115 | Active | Td | 139 |
Td(adult) unspecified formulation | 139 | Inactive | Td | 139 |
Td (adult), adsorbed | 09 | Active | Td | 139 |
Td (adult) preservative free | 113 | Active | Td | 139 |
Td (adult) | 138 | Active | Td | 139 |
Staphylococcus bacterio lysate | 76 | Inactive | ||
rubella/mumps | 38 | Inactive | RUBELLA | |
rubella/mumps | 38 | Inactive | MUMPS | |
rubella | 06 | Active | RUBELLA | |
RSV-MAb (new) | 145 | Pending | ||
RSV-MAb | 93 | Active | ||
RSV-IGIV | 71 | Active | IG | 14 |
rotavirus, unspecified formulation | 122 | Inactive | ROTAVIRUS | 122 |
rotavirus, tetravalent | 74 | Inactive | ROTAVIRUS | 122 |
rotavirus, pentavalent | 116 | Active | ROTAVIRUS | 122 |
rotavirus, monovalent | 119 | Active | ROTAVIRUS | 122 |
RIG | 34 | Active | IG | 14 |
Rift Valley fever | 73 | Never Active | ||
rheumatic fever | 72 | Never Active | ||
rabies, unspecified formulation | 90 | Inactive | RABIES | 90 |
rabies, intramuscular injection | 18 | Active | RABIES | 90 |
rabies, intradermal injection | 40 | Active | RABIES | 90 |
Q fever | 70 | Never Active | ||
polio, unspecified formulation | 89 | Inactive | POLIO | 89 |
pneumococcal, unspecified formulation | 109 | Inactive | ||
pneumococcal polysaccharide PPV23 | 33 | Active | PneumoPPV | 109 |
Pneumococcal Conjugate, unspecified formulation | 152 | Inactive | PneumoPCV | 109 |
pneumococcal conjugate PCV 7 | 100 | Active | PneumoPCV | 109 |
Pneumococcal conjugate PCV 13 | 133 | Active | PneumoPCV | 109 |
plague | 23 | Active | ||
pertussis | 11 | Inactive | ||
parainfluenza-3 | 69 | Inactive | ||
OPV | 02 | Inactive | POLIO | 89 |
Novel influenza-H1N1-09, preservative-free | 126 | Inactive | H1N1 flu | 128 |
Novel Influenza-H1N1-09, nasal | 125 | Inactive | H1N1 flu | 128 |
Novel Influenza-H1N1-09, all formulations | 128 | Inactive | H1N1 flu | 128 |
Novel influenza-H1N1-09 | 127 | Inactive | H1N1 flu | 128 |
mumps | 07 | Active | MUMPS | |
MMRV | 94 | Active | MMR | |
MMRV | 94 | Active | VARICELLA | |
MMR | 03 | Active | MMR | |
meningococcal, unspecified formulation | 108 | Inactive | MENING | 108 |
meningococcal MPSV4 | 32 | Active | MENING | 108 |
meningococcal MCV4P | 114 | Active | MENING | 108 |
Meningococcal MCV4O | 136 | Active | MENING | 108 |
meningococcal MCV4, unspecified formulation | 147 | Inactive | MENING | 108 |
Meningococcal C/Y-HIB PRP | 148 | Active | HIB | 17 |
Meningococcal C/Y-HIB PRP | 148 | Active | MENING | 108 |
meningococcal C conjugate | 103 | Inactive | MENING | 108 |
melanoma | 68 | Never Active | ||
measles | 05 | Inactive | MEASLES | |
malaria | 67 | Never Active | ||
M/R | 04 | Inactive | MEASLES | |
M/R | 04 | Inactive | RUBELLA | |
Lyme disease | 66 | Inactive | Lyme disease | |
leprosy | 65 | Never Active | ||
leishmaniasis | 64 | Never Active | ||
Junin virus | 63 | Never Active | ||
Japanese Encephalitis, unspecified formulation | 129 | Inactive | Japanese encephalitis | |
Japanese encephalitis SC | 39 | Active | Japanese encephalitis | |
Japanese Encephalitis IM | 134 | Active | Japanese encephalitis | |
IPV | 10 | Active | POLIO | 89 |
influenza, whole | 16 | Inactive | FLU | 88 |
influenza, unspecified formulation | 88 | Inactive | FLU | 88 |
influenza, split (incl. purified surface antigen) | 15 | Inactive | FLU | 88 |
influenza, seasonal, intradermal, preservative free | 144 | Active | FLU | 88 |
Influenza, seasonal, injectable, preservative free | 140 | Active | FLU | 88 |
Influenza, seasonal, injectable | 141 | Active | FLU | 88 |
influenza, live, intranasal, quadrivalent | 149 | Active | FLU | 88 |
influenza, live, intranasal | 111 | Active | FLU | 88 |
influenza, injectable, quadrivalent, preservative free | 150 | Active | ||
Influenza, high dose seasonal | 135 | Active | FLU | 88 |
influenza, H5N1-1203 | 123 | Inactive | H5N1 flu | |
influenza nasal, unspecified formulation | 151 | Inactive | FLU | 88 |
IGIV | 87 | Active | IG | 14 |
IG, unspecified formulation | 14 | Inactive | IG | 14 |
IG | 86 | Active | IG | 14 |
HPV, unspecified formulation | 137 | Inactive | HPV | |
HPV, quadrivalent | 62 | Active | HPV | |
HPV, bivalent | 118 | Active | HPV | |
HIV | 61 | Never Active | ||
Hib-Hep B | 51 | Active | HepB | 45 |
Hib-Hep B | 51 | Active | HIB | 17 |
Hib, unspecified formulation | 17 | Inactive | HIB | 17 |
Hib (PRP-T) | 48 | Active | HIB | 17 |
Hib (PRP-OMP) | 49 | Active | HIB | 17 |
Hib (PRP-D) | 46 | Inactive | HIB | 17 |
Hib (HbOC) | 47 | Inactive | HIB | 17 |
herpes simplex 2 | 60 | Never Active | ||
Hep E | 59 | Never Active | Hep E | |
Hep C | 58 | Never Active | HepC | |
Hep B, unspecified formulation | 45 | Inactive | HepB | 45 |
Hep B, dialysis | 44 | Active | HepB | 45 |
Hep B, adult | 43 | Active | HepB | 45 |
Hep B, adolescent/high risk infant | 42 | Inactive | HepB | 45 |
Hep B, adolescent or pediatric | 08 | Active | HepB | 45 |
Hep A-Hep B | 104 | Active | HepB | 45 |
Hep A-Hep B | 104 | Active | HepA | 85 |
Hep A, unspecified formulation | 85 | Inactive | HepA | 85 |
Hep A, pediatric, unspecified formulation | 31 | Inactive | HepA | 85 |
Hep A, ped/adol, 3 dose | 84 | Inactive | HepA | 85 |
Hep A, ped/adol, 2 dose | 83 | Active | HepA | 85 |
Hep A, adult | 52 | Active | HepA | 85 |
HBIG | 30 | Active | HBIG | |
hantavirus | 57 | Never Active | ||
DTP-Hib-Hep B | 102 | Inactive | HepB | 45 |
DTP-Hib-Hep B | 102 | Inactive | HIB | 17 |
DTP-Hib-Hep B | 102 | Inactive | DTAP | 107 |
DTP-Hib | 22 | Inactive | HIB | 17 |
DTP-Hib | 22 | Inactive | DTAP | 107 |
DTP | 01 | Inactive | DTAP | 107 |
DTaP-IPV-HIB-HEP B, historical | 132 | Inactive | POLIO | 89 |
DTaP-IPV-HIB-HEP B, historical | 132 | Inactive | HIB | 17 |
DTaP-IPV-HIB-HEP B, historical | 132 | Inactive | HepB | 45 |
DTaP-IPV-HIB-HEP B, historical | 132 | Inactive | DTAP | 107 |
DTaP-IPV | 130 | Active | DTAP | 107 |
DTaP-IPV | 130 | Active | POLIO | 89 |
DTaP-Hib-IPV | 120 | Active | HIB | 17 |
DTaP-Hib-IPV | 120 | Active | DTAP | 107 |
DTaP-Hib-IPV | 120 | Active | POLIO | 89 |
DTaP-Hib | 50 | Active | HIB | 17 |
DTaP-Hib | 50 | Active | DTAP | 107 |
DTaP-Hep B-IPV | 110 | Active | POLIO | 89 |
DTaP-Hep B-IPV | 110 | Active | HepB | 45 |
DTaP-Hep B-IPV | 110 | Active | DTAP | 107 |
DTaP,IPV,Hib,HepB | 146 | Pending | HepB | 45 |
DTaP,IPV,Hib,HepB | 146 | Pending | HIB | 17 |
DTaP,IPV,Hib,HepB | 146 | Pending | DTAP | 107 |
DTaP,IPV,Hib,HepB | 146 | Pending | POLIO | 89 |
DTaP, unspecified formulation | 107 | Inactive | DTAP | 107 |
DTaP, 5 pertussis antigens | 106 | Active | DTAP | 107 |
DTaP | 20 | Active | DTAP | 107 |
DT (pediatric) | 28 | Active | DTAP | 107 |
diphtheria antitoxin | 12 | Active | ||
dengue fever | 56 | Never Active | ||
CMVIG | 29 | Active | IG | 14 |
cholera | 26 | Inactive | cholera | 26 |
botulinum antitoxin | 27 | Active | ||
BCG | 19 | Active | BCG | |
anthrax | 24 | Active | ANTHRAX | |
adenovirus, unspecified formulation | 82 | Inactive | ADENO | 82 |
adenovirus, type 7 | 55 | Inactive | ADENO | 82 |
adenovirus, type 4 | 54 | Inactive | ADENO | 82 |
Adenovirus types 4 and 7 | 143 | Active | ADENO | 82 |
For further information on HL7 immunization data exchange and the CVX code set, contact the IIS Technical Assistance Team at:
CDC, National Centers for Immunization and Respiratory DiseasesEmail:
Immunization Information System Support Branch - Informatics
1600 Clifton Road
Mailstop: E-62
Atlanta, GA 30333
iisinfo@cdc.gov (note change)